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ABSTRACT 
To optimize survival and growth, bacteria have evolved adaptive behaviors that respond to 
relevant environmental signals. A switch from the motile to the sessile lifestyle is probably 
the most ancient behavioral transition of microorganisms. Gram-negative bacteria such as 
Salmonella species and Pseudomonas aeruginosa have a set of extracellular appendages 
involved in motility and biofilm formation, but also in interaction with the host. These 
appendages can be regulated by the bacterial second messenger cyclic di-GMP, which 
allows a millisecond fast response. 
The bacterial second messenger c-di-GMP regulates the transition between 
sessility and motility and between acute and chronic infection. In this work, the signaling 
pathway involved in motility in Salmonella enterica serovar Typhimurium has been 
investigated in detail. The phosphodiesterase YhjH specifically downregulates motility by 
interfering with the flagellar functionality. Three diguanylate cyclases inhibit motility in the 
yhjH background and interact specifically with one of two c-di-GMP receptors affecting 
motility (Paper 1). Also non-canonical EAL domain proteins such as STM1697 
unconventionally inhibit motility by post-transcriptionally interfering with the major flagellar 
regulator FlhD4C2 (Paper 2), which downregulates flagellin expression as one final outcome 
(Paper 2 and Paper 3). STM1697 has also an unconventional phenotype compared to EAL 
phosphodiesterases with respect to biofilm formation and invasion of the colon 
adenocarcinoma cell line HT-29 (Paper 2, Paper 4) and affects virulence mediated through 
the FlhD4C2 interaction (Paper 2). In general, c-di-GMP metabolizing proteins regulate 
virulence properties of S. Typhimurium such as invasion and production of the 
pro-inflammatory cytokine interleukin 8 by HT-29, but also secretion of the effector protein 
SipA from the invasion related type three secretion system and colonization of gut and 
organs in the streptomycin treated mouse (Paper 4). Surprisingly, c-di-GMP signaling inhibits 
virulence properties through biofilm components such as the major biofilm regulator CsgD 
and the cellulose synthase BcsA (Paper 4). These studies show that the c-di-GMP signaling 
network is involved in virulence in S. Typhimurium. In the last study, the human surfactant 
protein C an innate immune component of the lung, did not have an effect on bacterial 
growth, but affected biofilm formation and swarming motility of P. aeruginosa PAO1 
(Paper 5). 
In conclusion, this thesis sheds light on how the c-di-GMP signaling network 
and the surfactant protein C regulate the adaptive behavior of S. Typhimurium and 
P.  aeruginosa, respectively. 
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1 INTRODUCTION 
 
Bacteria express appendages on their cell surface for survival and virulence. 
These structures are important for motility, biofilm formation and the early stage of 
infection among other features. During interaction with higher organisms, these 
appendages can be recognized by the host and induce a defense response. 
To escape this attack, bacteria may adjust the expression or modify the structure of 
their surface appendages. 
 
1.1 GRAM-NEGATIVE SURFACE APPENDAGES: STRUCTURE AND 
FUNCTIONS 
Gram-negative or diderm bacteria exhibit different proteinaceous appendages on 
their cell surfaces that can be classified into at least six major classes based on their 
biosynthetic pathway1. Major proteinaceous surface appendages common to several 
bacteria are the flagellum, type three secretion injectisome, amyloid fibers such as 
curli and type IV pili. Non-proteinaceous appendages include lipopolysaccharide 
(LPS) and exopolysaccharide appendages such as cellulose.  
 
 Flagellum  1.1.1
The flagellum is an important surface structure involved in motility, biofilm formation 
and virulence2. The number and localization of the flagellum can vary significantly 
from one organism to another, for example Pseudomonas aeruginosa is 
monotrichous with one polar flagellum, while Salmonella enterica serovar 
Typhimurium is peritrichous with approximately 6 to 10 flagella arranged around the 
cell 3, 4. Assembly of this nanostructure is an ATP-driven process, but the rotation is 
directed by proton motive force5. The structure of this appendage can be divided in 
three parts: a long extracellular filament used as a propeller, a basal body, which 
spans across the membrane and contains the motor and a hook that connects the 
basal body with the filament6 (Fig. 1).  
Assembly of the flagellum in bacteria such as Salmonella species and 
Escherichia coli is hierarchically organized at the transcriptional level with three 
classes of promoters or transcriptional checkpoints7. In S. Typhimurium, the class 
one promoter genes encode the flagellar master regulator FlhD4C2. The class two 
promoter genes are transcribed upon activation by the heterodimer FlhD4C2 and the 
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RNA polymerase loaded with sigma factor 70. This class of genes encodes the 
components of the basal body and sigma factor 28 (FliA). The last transcriptional 
checkpoint is controlled by the anti-sigma factor FlgM that inhibits FliA. Once the 
hook basal body is completed, a substrate-specificity switch will lead to FlgM export 
and relieve inhibition of FliA to subsequently activate the transcription of the class 
three promoter genes6. This class of genes includes hook-associated proteins, motor 
components, filament subunits FliC and FljB and chemotaxis system proteins. 
In Pseudomonads, the sigma factor 54 acts together with the flagellar transcriptional 
activator FleQ to activate class two genes7.  
 
 
 
      
      
 
     
  
          
 Figure 1: Flagellum and injectisome representation. 
The flagellum and injectisome appendages are genetically, structurally and functionally 
similar. They are close in terms of evolution, their structure can be divided into three parts 
and the assembly of both appendages is conducted by the type three secretion system. 
Flagellum and the type three secretion injectisome have membrane-embedded export gates 
and a cytoplasmic complex containing an ATPase8. Both systems possess a molecular ruler 
to control the length of the flagellar hook or the injectisome needle9, 10. In the middle, 
cryo-electronmicroscopy image of membrane complex. OR: outer membrane ring, IR: inner 
membrane ring, OM: outer membrane, PG: peptidoglycan layer, CM: cytoplasmic 
membrane. Adapted from Kawamoto et al., 2013 11. 
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Export Apparatus 
Motor 
Components 
 3 
 
 Type three secretion injectisome 1.1.2
An intact injectisome was first observed in S. Typhimurium by electron microscopy 
and is studied now extensively by cryo-electronmicroscopy11, 12(Fig. 1). 
This membrane spanning nanostructure is a major virulence factor of the human 
pathogen S. Typhimurium, the plant pathogen P. syringae and other bacteria. 
The  main function of the injectisome is to manipulate the host cell by injection of 
effector proteins whereby the functions depend on bacterial lifestyles and infection 
modes13. This nanostructure can be divided into three parts: a basal body 
comparable to a channel, an export apparatus with a sorting platform, a needle or a 
pilus responsible for the translocation of effector proteins into the host cells14-16.  
In S. Typhimurium, the invasion associated type three secretion system 
(iT3SS) is mainly constituted of two pathogenicity islands; Salmonella pathogenic 
island 1 and 2 (SPI-1 and SPI-2)17, 18. The iT3SS-1 encoded on SPI-1 is necessary 
during the early stage of infection while the iT3SS-2 encoded on SPI-2 is required 
after invasion for bacterial replication and survival in the Salmonella containing 
vacuole in the host cell19, 20.  
The invasion process of S. Typhimurium can be divided into four 
steps:  (i) surface scanning and interaction with the mucosal surfaces, (ii) reversible 
binding mediated by the type 1 fimbriae, (iii) irreversible docking onto the host cell 
via the injectisome and (iv) manipulation of the host cell to allow invasion21. Effector 
proteins cooperatively mediate entry into the cell, for example SipA (Salmonella 
invasion protein A) encoded on SPI-1 directly binds actin and catalyzes its 
polymerization. Other iT3SS proteins such as SopE, SopE2 or SopB stimulate Rho 
family GTPases in the cell22-24. In complement, bacteria adjust their motility for 
surface scanning and use the metabolic products of the gut microbiota upon 
inflammation as energy sources to ensure successful invasion21, 25. As a major route 
of disease, Salmonella crosses the epithelial barrier of the gut by invasion of 
mucosal epithelial cells and induces inflammation after 4-8 hours24, 26. 
 
 Curli 1.1.3
Curli are amyloid fibers, 6-12 nm wide, resistant to protease and detergent attack. 
They are assembled by the type VIII secretion pathway and constitute an important 
component of the extracellular biofilm matrix27. In Salmonella species and E. coli, 
curli fibers are commonly coproduced with cellulose resulting in a biofilm, which 
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displays a distinct morphotype on Congo red agar plates. Biogenesis of curli requires 
two distinct curli subunit gene (csg) operons, csgBAC and csgDEFG28. CsgA is the 
major subunit protein of the fiber, while CsgB constitutes a minor 
subunit29 (Fig. 2 (A)). Export and assembly of CsgA is dependent on CsgG, a pore 
forming outer membrane lipoprotein and two periplasmic proteins CsgE and CsgF30, 
31. CsgD is a transcriptional regulator of the FixJ/LuxR family and is required for 
positive regulation of the curli production32. In P. aeruginosa, the fap operon 
encodes another class of amyloid fibers involved in biofilm formation33.      
 A      B 
 
 
 
 
 
 
 
 
 
Figure 2: Schematic representation of the curli and type IV pili 
(A) For curli biogenesis, the soluble major and minor subunits CsgA and CsgB are secreted 
across the outer membrane through the protein channel CsgG to form amyloid fibers. CsgA 
and CsgB contain a sec signal sequence that mediates their translocation across the inner 
membrane, which is cleaved of before passage through the porin forming protein CsgG. 
(B) The secretion system of the type IV pili is homologous of the type II secretion system. 
IM: inner membrane, OM: outer membrane, IMCP: inner membrane core protein. 
(A) Adapted from Goyal et al., 2014 and (B) Melville & Craig, 201334, 35. 
 
 Type IV pili 1.1.4
Type IV pili are cell surface polymers present in Gram-positive and 
Gram-negative bacteria (Fig. 2 (B)). They are flexible filaments of 1-4 µm length. 
A major function of type IV pili is twitching motility, associated with biofilm formation 
and bacterial virulence36. The pilus is constituted of the major pilin subunit called PilA 
and some minor pilins required for assembly or functionality35, 37. The secretion of 
PilA monomers to the cell surface requires the outer membrane secretin PilQ, while 
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two ATPases, PilB and PilC, are implicated in extension and retraction by 
assembling and disassembling PilA monomers38.  
 
 Cellulose and lipopolysaccharide 1.1.5
Cellulose is the most abundant biopolymer on earth produced by plants, fungi, 
animals and prokaryotes. In many bacteria including E. coli and S. Typhimurium, 
cellulose is one of the major components of the extracellular matrix of biofilm. 
This exopolysaccharide is composed of straight β-1-4 glucan chains associated by 
hydrogen bonds. In the model organism Gluconacetobacter xylinus, the cellulose 
macromolecules are crystalline fibrils located on the surface of the cell39. Cellulose 
production is associated with multicellular behavior and its expression can be 
monitored on Congo agar plate as a pink, dry and rough colony morphology40-42. 
In Enterobacteriaceae, synthesis of cellulose requires the two divergently transcribed 
bacterial cellulose synthesis (bcs) operons bcsABZC and bcsEFG28, 43. 
The membrane standing complex BcsAB contains the catalytic activity for cellulose 
synthesis44 (Fig. 3 (A)). BcsA is a membrane protein with a large cytoplasmic 
beta-glycosyltransferase 2 domain, which binds UDP-glucose and is responsible for 
the production of the linear glucan chain; and possess at the C-terminal end a PilZ 
c-di-GMP binding domain. The glucan chain is thought to be extruded through the 
outer membrane by the porin BcsC44, 45.  
                  A       B 
 
OM       
 
Periplasm 
IM 
 
 
Figure 3: Bacterial cellulose and LPS. 
(A) BcsA-BcsB is a large inner membrane complex with a large periplasmic and cytosolic 
part. The catalytic activity of this complex is located in BcsA as indicated by the arrow. 
The glucose and UDP are represented in blue and red respectively. (B) Export of LPS to the 
outer surface is made by a transmembrane transport complex constituted of seven proteins. 
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IM: inner membrane. OM: outer membrane. (A) Adapted from Morgan et al., 2013 and 
(B) Dong et al., 201344, 46.   
The lipopolysaccharide (LPS) is an essential component of the outer 
membrane of Gram-negative bacteria and is constituted of lipid A, core and variable 
O antigen (Fig. 3 (B)). In S. Typhimurium and P. aeruginosa, it constitutes an 
important virulence factor47. 
 
 Surface appendages as pathogen associated molecular pattern  1.1.6
Surface appendages are a primary target for the innate and adaptive immune 
response48, 49. Pathogen associated molecular patterns (PAMPs) are conserved 
microbial molecules not present in the eukaryotic host and thus represent an ideal 
target to be recognized by the innate immune response. Surface appendages are 
recognized by pattern recognition receptors (PRRs) in the host. Some of the most 
studied PRRs belong to the toll like receptor (TLR) family. PAMPs, more correctly 
designated as MAMPs (microbial- associated molecular pattern), include, for 
example LPS and curli recognized by TLR-4 and TLR-2, TLR-1 and cluster of 
differentiation 14 (CD-14) respectively50, 51. 
Bacterial flagellin is a well-characterized PAMP recognized by PRR in 
mammalian cells and the plant host. In mammals, flagellin is a ligand for cell bound 
and cytosolic receptors, which include TLR-5 and Nod-like receptors NAIP5 and 
IPAF52-54. Binding of flagellin to these receptors triggers downstream events such as 
pro-inflammatory response and apoptosis54.  
 The flagellin monomer is constituted of four domains: D0, D1, D2 and 
D3. The conserved domain D1 is recognized by TLR-5 and exposed in monomeric 
flagellin55.  The flagellar filament consists of 11 protofilaments that are assembled in 
a helix like manner (Fig. 4 (C)). 
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Figure 4: Schematic representation of flagellin domain structure and binding 
to TLR-5. (A) Four domains D0, D1, D2 and D3 compose the flagellin monomer. (B) Top 
view of the 11 proto-filaments. (C) Longitudinal view of one protofilament with helical 
structure. (D) Flagellin and TLR-5 receptor complex. Adapted from Tanner et al., 2011 and 
Yoon et al., 201256, 57. 
 
TLR-5 binding to flagellin can be investigated in vitro with the human 
colon adenocarcinoma cell line HT-29. HT-29 does not express TLR-4, which 
recognizes LPS. Downstream events of TLR-5 recognition of flagellin such as 
production of the pro-inflammatory cytokine interleukin 8 (IL-8) or NF-kB activation 
can be used as biological readout to evaluate the TLR-5-flagellin interaction58. 
 
 Phase variation and bistable expression of surface appendages 1.1.7
To avoid recognition by the host or for energy saving, bacteria can regulate the 
expression of their surface appendages. Two main mechanisms are phase variation 
and bistable expression. Phase variation is mainly characterized as an ON-OFF 
system. It occurs in a stochastic manner, but with higher frequency than random 
mutations. Phase variation is common in Gram-negative bacteria and associated 
with evasion of the host immunity. Major molecular mechanisms of phase variation 
are site-specific recombination, gene conversion, epigenetic modification, nested 
DNA inversion and slipped strand mispairing. For example, the Salmonella flagellar 
switch from flagellin FliC to FljB can be described as an antigenic switch in a phase 
variation manner (ON-OFF) caused by site-specific inversion of the promoter region 
of the fljBA operon59, 60 (Fig. 5).  
D 
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Figure 5: Simplified schema of flagellar phase variation. 
During the phase H1, FljB and FljA are expressed. FljA is a transcriptional and post-
translational repressor of the phase H2. In the phase 2, the DNA invertase complex Hin/Fis 
inverts the promoter region of fljBA and fljB and fljA are not transcribed. fliC is transcribed as 
fljA transcription is repressed. Adapted from Bonifield and Hughes, 2003 and Hughes 
et al., 19924.   
 
Bistability describes coexistence of two distinct populations with an all or 
nothing expression pattern in the same isogenic cell population61. For example, the 
expression of flagella or the biofilm activator CsgD are bistably expressed in 
Salmonella62. Even during the motile phase, not all the cells express flagella. 
Regulation of this bistability occurs at the post-translational level by interference with 
the class 1 transcriptional regulator FlhD4C2. FlhD4C2 functionality is repressed by 
the non-canonical EAL domain proteins YdiV and STM169763, 64. Bistable expression 
is not only restricted to the flagellum system, the injectisome is also subject to 
bistable expression65. One other biological reason for bistability can be found in 
energy saving for the population. In LB batch culture, it has been observed that 
bacteria expressing the effector proteins from the SPI-1 locus have a growth 
disadvantage (retardation) compared to the part of the population not expressing 
effector proteins66. This observation was also made at the single cell level and, with 
growth retardation correlated with an increase in antibiotic resistance67.  
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1.2 BIOFILMS 
The multicellular lifestyle, commonly called biofilm formation, is one of the most 
widespread and ancient adaptive behaviors of microorganisms68. Biofilms are 
defined “as matrix-enclosed bacterial populations adherent to each other and/or to 
surfaces or interfaces”69. A biofilm consortium can be composed of different 
microorganism such as bacteria, fungi or other unicellular organisms such as algae 
and amoeba. The extracellular matrix is variable depending on the microorganisms’ 
composition, exerted forces, growth condition, surface, temperature, nutrient 
availability and other parameters70. The extracellular matrix consists of 
exopolysaccharides, protein, nucleic acids such as eDNA and lipids. Proteinaceous 
appendages such as flagella, pili and fimbriae contribute to adherence and biofilm 
matrix stabilization71. The biofilm developmental cycle can be dissected in distinct 
steps; initial and reversible attachment, irreversible binding, formation of 
microcolonies, development of a biofilm structure and maturation, detachment and 
dispersion. Surface appendages are essential during almost all steps of biofilm 
formation72.  
Prior and during the initial attachment, surface structures such as the 
flagella or pili are important for sensing the surface and to give a ”landing 
permission”. For example, in P. aeruginosa, type IV pili play a complementary role to 
the Pel polysaccharide biosynthesis locus to slingshot the bacteria on the surface73.  
Irreversible attachment is mediated by formation of extracellular matrix 
components, for example, exopolysaccharide. The period to switch from reversible 
to irreversible attachment is highly variable depending on the microorganism74. 
The transition between microcolonies and mature biofilm is mainly driven by 
metabolic changes and extensive production of extracellular matrix72. Detachment of 
cells from mature biofilm involves specific environmental stimuli, signal transduction 
pathways and effectors75, 76. 
The composition of the biofilm is highly variable depending on 
environmental conditions, the microorganisms and the surface colonized. 
The microorganisms may only constitute 10% of the biofilm, while the extracellular 
matrix contributes 90% of the mass of the biofilm. In the intestine, the microflora 
forms a biofilm-like community that promotes physiological functions such as 
digestion, provides a protection barrier from pathogen invasion of the mucosal 
epithelium and strengthens the host defense77. On the other hand, biofilm formation 
in enteric pathogens can promote colonization and confer protection from host 
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immune defenses such as antimicrobial peptides. S. Typhimurium is one pathogen 
that takes advantage of the disruption of the resident intestinal microbiota after 
antibiotic treatment. This enteric pathogen adheres to the intestinal epithelium with 
its surface appendages like fimbriae and curli and forms a pathogenic biofilm on 
biotic surfaces such as gallstones within 14 days78. Salmonella biofilm formation can 
be analyzed in the laboratory as pellicle formation at the air-liquid interface in 
lysogenic broth (LB), a ring in adherence test medium (ATM) or the rdar (red, dry 
and rough) morphotype on Congo red agar plates43, 79, 80. 
The master regulator of biofilm formation in S. Typhimurium is the 
response regulator CsgD, which constitutes a major hub in the regulation of rdar and 
pellicle biofilm81. The expression of csgD in the stationary phase is dependent on 
RpoS, an alternative sigma factor, and other global regulators82. The RNA 
chaperone Hfq and Hfq dependent sRNAs are involved in csgD regulation at the 
transcriptional and post-transcriptional levels. The carbon storage regulator CsrA, a 
global RNA-binding protein, also plays an important role in modulation of the biofilm 
phenotype in S. Typhimurium83. 
 
1.3 THE CYCLIC DI-GMP SIGNALING NETWORK 
First discovered in Gluconacetobacter xylinus in 1987 as an activator of the cellulose 
synthase, cyclic-di-GMP (C-di-GMP) has been extensively investigated84. In 2004, 
three research groups independently “rediscovered” c-di-GMP and defined its role as 
second messenger of bacteria85-87. In addition, the biofilm motility switch paradigm 
was postulated85 . More recently, c-di-GMP network were dissected in many bacteria 
and eukaryotic c-di-GMP receptors in mammalians were identified85. Since then, the 
interest for this molecule has been growing, which cumulatively resulted in more 
than 650 scientific articles about c-di-GMP to date.  
 
 C-di-GMP signaling network architecture 1.3.1
1.3.1.1 Articulations of the network: Enzymes responsible for c-di-GMP turnover  
Usually, a first messenger signal is exponentially amplified by enzymatic production 
of a second messenger. The intracellular level of the second messenger        
c-di-GMP is regulated by diguanylate cyclase (c-di-GMP synthesis) and 
phosphodiesterase (c-di-GMP degradation) activity. Two molecules of guanosine 
triphosphate (GTP) serve as substrate for c-di-GMP formation with the intermediate 
product pppGpG. The diguanylate cyclase domain contains a GG(D/E)EF 
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(Gly-Gly-Asp/Glu-Glu-Phe) motif involved in the enzymatic activity; the condensation 
of the two GTP. The c-di-GMP synthesis with phosphodiester bond formation 
requires a GGDEF domain homodimer in antiparallel conformation and the presence 
of divalent manganese (Mn2+) or magnesium (Mg2+) ions (Fig. 6). The third amino 
acid of the motif, which can be a D (aspartate) or E (glutamate), is involved in 
catalysis, a mutation of D/E to A (Alanine) abolishes the enzymatic activity88. 
Approximately 60 % of the GG(D/E)EF proteins, like PleD of Caulobacter 
crescentus, contain a product binding site characterized by an RXXD motif 
(X corresponds to any amino acid) or ”I-site” (I for inhibitory) located five amino acids 
upstream of the GGDEF motif. Upon c-di-GMP binding to the “I-site”, allosteric 
repression or product inhibition occurs which restricts the activity of the diguanylate 
cyclases89, 90.  
 
 
 
 
                 GGDEF domain   EAL domain  
2 x GTP          
              HD-GYP   
 
 
 
 
 
Figure 6:  C-di-GMP metabolism and enzymatic components involved. 
Synthesis and degradation of c-di-GMP involves diguanylate cyclases and 
phosphodiesterases. The diguanylate cyclase activity, which performs synthesis of 
c-di-GMP, contains a GGDEF domain and is represented by WspR from P. aeruginosa. 
The phosphodiesterases performing the degradation of c-di-GMP contain an EAL or 
HD-GYP domain. Adapted from De et al., 2008, Kalia et al., 2013 and Wigren et al.,201491-93. 
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C-di-GMP 
2 x 5´-pGpG 
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Degradation of c-di-GMP is mediated by phosphodiesterases with EAL 
(Glu-Ala-Leu) or HD-GYP (His-Asp-Gly-Tyr-Pro) domain. Hydrolysis of the c-di-GMP 
phosphodiester bond leads to the linear di-nucleotide (5´-pGpG) for the EAL and 
guanosine monophosphate (GMP) for the HD-GYP domain. In the case of the EAL 
domain, degradation of c-di-GMP requires Mn2+ or Mg2+ and is inhibited by Ca2+ ions. 
Although a phosphodiesterase activity has been observed for an EAL domain 
monomer, EAL domains perform optimal catalytic activity as dimers or oligomers94. 
The majority of the EAL domains contain a conserved motif DFG(T/A)GYSS 
comprising loop 6 implied in maintenance of the secondary structure of the EAL 
domain and the substrate binding activity95. Structural analysis of the 
phosphodiesterase RocR from P. aeruginosa revealed seven amino acids required 
for Mg2+ positioning (Fig. 6). The phosphodiester bond breakage is the result of the 
nucleophilic attack of the resulting OH- after proton acceptation from a water 
molecule by the general catalytic base glutamate E in the EGVF motif96.  
The EAL domain proteins can be classified into three classes. The first 
class contains conserved consensus signature motifs and a conserved loop 6. 
Class 1 EAL domains are bona fide phosphodiesterases. Member of class 2 EAL 
domains do not necessarily behave as phosphodiesterases. They have 
semi-conserved consensus sequences and a degenerated loop 6 such as the 
phosphodiesterase STM3611 (YhjH) in S. Typhimurium. The class 3 EAL domains 
also contain a degenerated loop 6 and lack residues required for catalysis and 
c-di-GMP binding activity. Class 3 domain proteins are, for example, STM1697 and 
YdiV, in S. Typhimurium94.  
The other hydrolases that degrade c-di-GMP are the HD-GYP domain 
proteins. The difference in the degradation product between EAL domains and 
HD-GYP domains is due to the high efficiency to break down the intermediary 
product 5´-pGpG by the HD-GYP domain. The first HD-GYP identified was RpfG in 
Xanthomonas campestris97. Lately, the crystal structure of the active HD-GYP 
protein Pm-GH revealed the presence of a trinuclear Fe center and an optimal 
conformation of the catalytic site that allows complete hydrolysis of c-di-GMP into 
two molecules of GMP98.  
GGDEF-EAL as tandem domains in one protein occurs in 1/3 of the GGDEF 
domain and 2/3 of the EAL domain proteins. In the tandem proteins, the individual 
domains can have diguanylate cyclase and phosphodiesterase activity, one of the 
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enzymatic activities or can be both inactive. GGDEF-HD-GYP tandems exist to a 
lesser extent99.  
 
1.3.1.2 Distribution of c-di-GMP metabolizing proteins in the bacterial kingdom 
The c-di-GMP metabolizing proteins are present in all the branches of the bacterial 
kingdom99. Within the same phylum or even the same genus, the number and 
identity of the members of the c-di-GMP signaling network can be different, but is 
roughly linear to the genome size100. Usually, a change to an invasive lifestyle is 
accompanied by a reduction of the c-di-GMP signaling network components. 
For example, Shigella species have a reduced c-di-GMP network compared to 
E. coli (U. Römling-personal communication). The S. Typhimurium signaling network 
contains 20 proteins, 5 GGDEF domain proteins, 8 EAL domain proteins and 
7 GGDEF/EAL domain proteins (Fig. 7). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7: Venn diagram representing the GGGDEF/EAL domain proteins in 
S. Typhimurium. The c-di-GMP signaling network in one bacterial strain usually consists 
of numerous proteins containing a GGDEF and/or EAL domain. In S. Typhimurium as well 
as in other bacteria, the majority of the c-di-GMP turnover proteins are associated with a 
N-terminal signaling or sensory domain such as PAS, HAMP, MHYT and PAS-PAC. 
Sensory domains are more frequently present in GGDEF and GGDEF-EAL domain than in 
EAL domain proteins100. Adapted from Simm, 2007101. 
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1.3.1.3 C-di-GMP receptors and effectors as conveying system  
The c-di-GMP receptors and effectors transmit the secondary messenger signal to a 
physiological output (Fig. 7). The identification of novel c-di-GMP receptors is 
essential to understand how c-di-GMP modulates biological functions. C-di-GMP 
receptors have been identified by bioinformatic prediction, biochemical analysis and 
structural biology90, 99, 102, 103. 
Regulation of intracellular levels of c-di-GMP by the turnover proteins 
modulates diverse bacterial behavior and physiology such as biofilm formation, 
motility, virulence and the cell cycle through the c-di-GMP receptors99, 103. Several 
classes of c-di-GMP receptors have been identified, among them the PilZ domain 
proteins, degenerated GGDEF and EAL domain proteins, transcription factors and 
different riboswitches. The c-di-GMP monomer or higher oligomeric structures are 
usually recognized by short signature motif(s) in the receptors104. The c-di-GMP 
molecule is binding to different motifs due to its high conformational flexibility104.   
 A main c-di-GMP receptor family is the PilZ domain protein family. 
Discovered in 2006, this domain was predicted by bioinformatics analysis and 
c-di-GMP binding was confirmed by experimentation105, 106. The N-terminus of most 
PilZ domains contains two highly conserved motifs, a (Q/E)RRXXXR and a DZSXXG 
motif involved in c-di-GMP binding (X corresponds to any amino acid residue and Z 
to any hydrophobic residue)97. Binding of c-di-GMP to PilZ domain proteins can 
occur with different stoichiometry, affinity and conformation and usually leads to a 
significant conformational change103. Frequently, the same organism contains 
numerous PilZ domain proteins. S. Typhimurium contains two PilZ domain proteins, 
the flagellar functionality regulator YcgR and the cellulose synthase BcsA. C-di-GMP 
binds with the same stoichiometry to these two PilZ domain proteins, but with highly 
different affinities, 43 fold higher for YcgR than BcsA107. Another c-di-GMP receptor 
family, is part of the larger cAMP receptor protein family. The first identified protein to 
bind c-di-GMP was the transcriptional regulator Clp in Xanthomonas campestris. 
Mutation in the c-di-NMP (N stand for nucleotide) binding site of this protein 
abolished the ability of Clp to bind c-di-GMP and to target promoters regulating 
virulence factor genes108.  
The degenerated GGDEF domains harboring the “I-site” can still act as 
receptors, and upon c-di-GMP binding, be involved in regulation of cellular 
processes. For example, the membrane protein PelD of P. aeruginosa regulates 
exopolysaccharide synthesis in response to c-di-GMP binding to the RXXD 
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domain109. The response regulator PopA regulates in a similar way cell cycle 
progression in C. crescentus. In S. Typhimurium, the GIL domain protein BcsE is 
required for maximal cellulose production and binds c-di-GMP by the RXGD motif110. 
Also degenerated EAL domain proteins have been identified as potential c-di-GMP 
receptors. The inactive GGDEF-EAL domain protein LapD from Pseudomonas 
fluorescens regulates cell association of the adhesin LapA by scavenging the 
periplasmic protease LapG upon c-di-GMP binding111. In P. aeruginosa, the flagellar 
transcriptional regulator FleQ controls exopolysaccharide production by repressing 
the pel promoter in the absence of c-di-GMP, while relieving repression in the 
presence of c-di-GMP112.  
Last but not least, c-di-GMP has been identified as a small molecule binding 
to the 5´ UTR (untranslated region) of the mRNA to alter gene expression, a 
so-called riboswitch. Thereby, c-di-GMP regulates diverse cellular functions such as 
flagella based motility, virulence gene expression and pilus formation113. So far, two 
different classes of riboswitches have been identified that bind c-di-GMP114, 115. 
 
1.3.1.4 Stimuli and sensory domains  
C-di-GMP metabolizing proteins are usually linked to a signaling, input or sensory 
domain, which is sensing the first messenger. Sensory domains frequently 
associated with c-di-GMP turnover proteins are PAS, GAF-PHY, hemerythrin and 
the REC domain. These domains are mostly located at the N-terminal part of the 
c-di-GMP metabolizing protein99. These domains sense, for example, O2, NO, light, 
quorum sensing or are regulated by phosphotransfer116. 
 
1.3.1.5 Non-canonical EAL domain proteins 
The non-canonical EAL domain proteins belong to the class 3 EAL domain proteins. 
These proteins are highly homologous to EAL domains, but lack the determinative 
consensus amino acids signature and consequently do not have the enzymatic 
activity or even do not bind c-di-GMP94. These proteins are usually involved in 
protein-protein interactions and are often still part of the c-di-GMP signaling network. 
One of the well-studied non-canonical EAL proteins is YdiV (STM1344) of 
S. Typhimurium and E. coli. The main function of YdiV is to bind the major activator 
of the flagellar regulon FlhD4C2 and repress its binding to the promoter DNA. 
YdiV also acts as a putative adaptor to target FlhD4C2 for ClpXP-dependent 
proteolysis117. Another example of a non-canonical EAL domain protein is STM1697, 
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present only in S. Typhimurium, which regulates biofilm formation, motility and 
invasion, also by interference with FlhD4C2 functionality
64.  
 
 Regulation of cellular function by c-di-GMP 1.3.2
C-di-GMP controls a wide range of physiological functions spanning from 
photosynthesis to virulence in a wide variety of bacteria from almost every branch of 
the phylogenetic tree. The c-di-GMP signaling pathway (Fig. 8) occurs in 
environmental as well as pathogenic bacteria. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8: First messengers, second messengers, effectors, outputs. 
Second messengers such as c-di-GMP in bacteria are regulated in response to 
environmental and intracellular stimuli (first messengers) and bind receptors and effectors in 
the cell. These receptors and effectors will induce specific outputs. Adapted from 
Agostini et al., 2014118. 
 
1.3.2.1 Regulation of biofilm formation by c-di-GMP 
C-di-GMP is regulating directly or indirectly each step of the biofilm cycle99. During 
initial attachment, c-di-GMP regulates, among other physiological events, the 
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formation of extracellular appendages. The GGDEF-EAL domain protein LapD from 
P. fluorescens mediates bacterial attachment through the maintenance of the 
adhesin LapA on the cell surface119. Biogenesis of the type IV pili required for 
surface scanning before microcolony formation is stimulated by c-di-GMP in 
P. aeruginosa and other bacteria73. C-di-GMP modulates the production of the 
extracellular matrix that converts the microcolonies to mature biofilm structures120, 
121. For example, c-di-GMP stimulates the production of the matrix component, the 
exopolysaccharide poly-β-1, 6-N-acetylglucosamine. Synthesis of this extracellular 
matrix component occurs through c-di-GMP binding to the two inner membrane 
proteins PgaC and PgaD122. Another important component of biofilm regulated by 
c-di-GMP is the eDNA that promotes construction of an intricate network of 
furrows123, 124. Dispersal of the biofilm is regulated by the concomitant action of 
phosphodiesterases and non-toxic level of exogenous nitric oxide in P. aeruginosa 
and other bacteria125. 
In S. Typhimurium, CsgD is the major hub for positive regulation of biofilm 
formation and production of extracellular matrix components. This transcriptional 
factor of the LuxR family activates curli fimbriae expression and the transcription of 
adrA (AgfD regulated protein A) encoding, a diguanylate cyclase involved in 
cellulose biosynthesis. The expression of CsgD is regulated by at least six 
GGDEF/EAL domain proteins. CsgD is expressed in a bimodal way in the biofilm, 
but high concentration of c-di-GMP abolishes in the cell population the variability62, 
126, 127. In ATM medium, the GGDEF domain protein STM1987 is involved in 
cellulose production128. To activate cellulose biogenesis, c-di-GMP binds to the 
C-terminal PilZ domain of the cellulose synthase BcsA. This binding activates the 
BcsA-BcsB complex by breaking a salt bridge that releases the complex from an 
auto inhibited state and allows access to substrate and substrate coordination at the 
active site (Fig. 3)129.  
 
1.3.2.2 Regulation of motility by c-di-GMP 
Depending on the bacterial species, the c-di-GMP may be involved in regulation of 
the flagellum at the transcriptional, post-transcriptional, post-translational and 
functional level7. In S. Typhimurium, c-di-GMP regulates the flagellum, motor speed 
and rotation at the functional level. C-di-GMP binds to the PilZ domain protein YcgR. 
YcgR interacts with the motor component FliG and induces a bias in flagella rotation 
(Fig. 1)130, 131. The other PilZ domain protein, BcsA, is also involved in motility 
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regulation. High concentration of c-di-GMP will promote the cellulose synthase that 
provokes an accumulation of cellulose around the cell and hampers flagella 
rotation132. At the transcriptional level, the RNA binding protein CsrA positively 
regulates FlhD4C2 by increasing its binding activity and preventing the repression of 
the heterodimer by the two non-canonical EAL domain proteins YdiV and 
STM169764, 133.  
In addition to regulating the transition between motility and biofilm formation, 
c-di-GMP regulates the cell polarity and morphology of C. crescentus and couples 
this events with DNA replication and cell division134. 
 
1.3.2.3 C-di-GMP regulation of virulence 
Different virulence phenotypes can be affected by c-di-GMP in human, animal and 
plant pathogens. For example, c-di-GMP signaling regulates adherence to and 
invasion of the host cells, intracellular infection and modulation of the immune 
response99, 135. In S. Typhimurium, high concentrations of c-di-GMP affect secretion 
of monomeric flagellin, bacterial invasion of an epithelial cell line and secretion of 
IL-8136. During infection by V. cholerae, the bile present in the lumen of mice and 
humans causes an increase in c-di-GMP concentration, while after entry into the 
mucosal layer, pH augmentation might decrease the concentration of c-di-GMP137. 
Furthermore, low levels of c-di-GMP through the action of the phosphodiesterase 
VieA subsequently activate cholera toxin production86. In P. aeruginosa, the clinical 
phenotype “small colony variant” (SCV) is associated with a high level of c-di-GMP. 
The YfiBNR operon can regulate the SCV phenotype. Mutant of yfiR encoding a 
negative regulator of the diguanylate cyclase YfiN exhibited a strong resistance to 
phagocytosis by macrophages138.  
Recently, one activator of the type 1 interferon production, STING (STimulator 
of INterferon Gene) has been identified as one of the specific cytosolic receptors of 
c-di-GMP139. Several articles have highlighted the immunostimulatory and 
immunomodulatory properties of c-di-GMP and its possible utilization as an adjuvant 
for the development of mucosal vaccines. The second messenger has been shown 
to have a variety of immunomodulatory effects, among others to stimulate dendritic 
cells and to produce several key cytokines140. In vivo, pretreatment of mice with 
c-di-GMP induces a protective effect against mucosal bacterial challenges140-142. 
The adjuvant properties of c-di-GMP have already been used in the development of 
a live attenuated vaccine for influenza H5N1 virus143. Furthermore, c-di-GMP has 
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been shown to inhibit the proliferation of colonic cancer cells in vitro and to improve 
vaccination against metastatic breast cancer144, 145. 
 
1.4  HOST COMPONENTS REGULATING BACTERIAL BEHAVIOR 
 
 Interactions between host components and biofilm bacteria 1.4.1
Microbial biofilm in the host is a bacterial virulence and defense mechanism leading 
to chronic infection. Formation of biofilm confers protection to bacterial communities 
against the hostile environment by limiting penetration of leukocytes into the biofilms, 
decrease of the macrophage phagocytic capacity and increased tolerance to 
antibiotics146. However, certain components of the innate immune defense such as 
the antimicrobial peptide LL-37 expressed by neutrophils and epithelial cells are 
active against biofilm formation in a wide range of bacteria, for example, LL-37 
inhibits adherence of bacteria, dissolves mature biofilms and downregulates 
cell-to-cell communication in P. aeruginosa, E. coli and Staphylococcus epidermidis 
biofilms147-149. A prototype of a biofilm infection in humans is infection of the lung of 
cystic fibrosis patients by P. aeruginosa150. 
The lung is a zone of gas exchange between the environment and host. This 
organ is composed of respiratory bronchioles, alveolar ducts and alveolar sacs. In 
the lung, protective immune responses spans from cilial movement to alveolar 
macrophages and defensins150. The surfactant proteins (SPs) are present at the 
air/surface interface. Surfactants prevent the lung to collapse at expiration. 
The functions of the surfactant proteins include protection of the host from microbial 
contamination challenge by different mechanism as listed in Table 1. 
 
 
Name Property Family Interaction with bacterial surface 
appendages 
SP-A Hydrophilic Collectin Flagellin151, adhesin152 LPS153 
SP-B Hydrophobic Saposin LPS154 
SP-C Hydrophobic - LPS155 
SP-D Hydrophilic Collectin Flagellin156, adhesin157, LPS158 
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Table 1: Surfactant proteins present in the human lung.  
Collectins are collagenous carbohydrate-binding proteins. This family is directly involved in 
innate immunity by their ability to bind pathogens as diverse as viruses, bacteria and fungi. 
They counteract pathogen invasion in the lung by promoting aggregation of pathogens, 
stimulation of phagocytosis and modulation of the inflammatory response. The saposins 
have well conserved structural elements and SP-B is expected to have a similar structure as 
the antimicrobial peptide NK-lysin. Adhesins, which interacts with the surfactant protein A 
include Eap in Staphylococcus aureus and FimH of uropathogenic E. coli. Adapted from 
Almlén, 2010159. 
 
 Role of surfactant protein C  1.4.2
The surfactant protein C (SP-C) is a hydrophobic membrane standing polypeptide. 
In the lung, the type two alveolar cells express the pro-SP-C gene located on the 
chromosome 8160. A deficiency in SP-C can conduct to an acute respiratory failure 
and interstitial lung disease, but can be treated with artificial surfactant 
replacement161. SP-C can interact with the bacterial components like the LPS, 
nevertheless its role in lung immunity remains unclear162, 163. 
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2 AIMS OF THE THESIS 
The overall aim of this thesis was to understand how a secondary signaling molecule 
and a component of the host innate immune system regulate bacterial behavior.  
 
The specific aims of this thesis were: 
 (i) To dissect the c-di-GMP signaling network regulating motility in S. Typhimurium 
 Determination of the c-di-GMP synthesizing proteins contributing to motility 
inhibition (Paper 1). 
 Determination of c-di-GMP receptors corresponding to c-di-GMP synthesizing 
proteins (Paper 1). 
 Determination of the molecular mechanism by which the non-canonical 
protein STM1697 regulates motility, virulence properties and biofilm formation 
(Paper 2). 
 
 (ii) To dissect how c-di-GMP signaling regulates virulence properties of 
S. Typhimurium  
 Characterization of the c-di-GMP signaling network involved in invasion of 
S. Typhimurium into the host cell line HT-29 (Paper 2 and 4). 
 Evaluation of the c-di-GMP signaling network relevant in invasion, which 
regulates secretion of the effector protein SipA (Papers 2 and 4). 
 Identification of the c-di-GMP signaling network, which regulates the secretion 
of  IL-8 (Paper 4). 
 
(iii) To identify surfactant protein C (SP-C) regulated bacterial virulence related 
phenotypes in P. aeruginosa  
 Determination of the minimum inhibitory concentration of SP-C on bacterial 
growth (Paper 5). 
 Analyze the effect of SP-C on biofilm formation and motility (Paper 5). 
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3 MATERIAL AND METHODS 
The general principles of major techniques used in this thesis are described. A more 
broad description of the protocols that were used can be found in the Materials 
& Methods section of the respective papers. 
 
3.1 BACTERIAL STRAINS 
 
 Salmonella enterica serovar Typhimurium 3.1.1
S. Typhimurium is a Gram-negative bacterium belonging to the family of 
Enterobacteriaceae. This bacterium is one of the most important food-borne 
pathogens and follows an oral-fecal route of transmission in humans. From 12 to 
36 hours after consumption of contaminated food, symptoms of Salmonellosis such 
as abdominal cramps, fever, and diarrhea are appearing. In healthy humans, 
recovery from symptoms occurs without medication, but total intestinal recovery can 
take several months164. S. Typhimurium causes a systemic infection in Salmonella 
susceptible mice similar to S. Typhi in humans, which constitutes a genetically 
traceable model to study typhoid fever. Another relevant model is infection of 
streptomycin treated mice, which mimics human gastroenteritis26. S. Typhimurium 
can be conveniently grown and genetically manipulated. Two of the most common 
genetic engineering tools in S. Typhimurium are λ red recombination and phage 
transduction165, 166. The λ red recombination allows gene replacement with an 
antibiotic cassette by efficient homologous recombination requiring only 40 base 
pairs of homology. Phage transduction is based on the ability of the prophage P22 
HT105/1 int-201 to pack and transfer genomic DNA from one bacterial strain to 
another. A selectable marker allows selection of mutated gene alleles. The bacterial 
strain used in these studies as the wild type strain is S. Typhimurium UMR1, 
ATCC14028-1s-Nalr, a single colony nalidixic acid resistant isolate, expressing the 
rdar morphotype at 28°C40. 
 
 Pseudomonas aeruginosa PAO1 3.1.2
P. aeruginosa is an ubiquitous Gram-negative bacterium belonging to the 
Gammaproteobacteria. P. aeruginosa is one of the most frequent nosocomial 
pathogens mainly due to its ability to form biofilms167. P. aeruginosa PAO1 is one 
genetic reference strains isolated from a wound infection in Melbourne, Australia, in 
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1954 and the background strain used in this study. This is a reference strain for 
genetic and phenotypic analysis of P. aeruginosa168.  
 
3.2 BACTERIAL VIABILITY ASSAY 
In clinical routine, determination of minimum inhibitory concentration (MIC) and 
minimum bactericidal concentration (MBC) of an antimicrobial drug is regulated by 
established protocols. Clinical breakpoints are published by the European 
Committee on Antimicrobial Susceptibility Testing169. To evaluate the bactericidal or 
bacteriostatic activity of a compound such as the surfactant protein C, bacteria were 
inocculated in liquid medium containing different concentrations of the antimicrobial 
agent. The test conditions used were similar to conditions used for evaluation of 
cationic antimicrobial peptides and followed EUCAST recommendations170.  
 
3.3 PHENOTYPIC ANALYSIS 
Major bacterial behavior relevant to virulence, motility and biofilm formation was 
investigated in this work. Assays were used in the context of gene deletion and 
complementation in S. Typhimurium and to assess the effect of SP-C on physiology 
of P. aeruginosa. 
A                         B  C 
 
 
 
 
Figure 9: Example of phenotypic assays used in this thesis.  
(A) Different biofilm models used. Colony morphology on Congo red agar plates, biofilm 
formed on polypropylene or polystyrene support171. Flagella based (B) swimming and (C) 
swarming motility. 
 
 Biofilm assays 3.3.1
3.3.1.1 Rdar morphotype biofilm 
Bacterial spotting on Congo red plate is a convenient tool to characterize 
genotype-biofilm phenotype relation42. Observation of colony morphology and color 
of the spot after 48 h of incubation at 28°C can give information at the level of biofilm 
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formation and composition of the extracellular matrix. The reference strain 
S. Typhimurium UMR1 displays a wild type red, dry and rough colony phenotype53. 
The color development is dependent on the composition of the extracellular biofilm 
matrix where cellulose is producing a pink colony and curli are producing a brown 
colony34 (Fig. 9). This analysis can be complemented by western blot analysis 
assessing expression of the major biofilm regulator CsgD. The level of expression of 
CsgD is directly correlated with rdar morphotype development42, 171. 
 
3.3.1.2 Biofilm formation on abiotic surfaces 
Adherence and biofilm formation to an abiotic surface under steady state conditions 
allows monitoring of biofilm development over time. This frequently used assay is 
performed in 96 well microtiter dishes for genetic screening or to assess the effect of 
various growth media on biofilm formation. Staining of bacterial cells with crystal 
violet allows visualization of microbial adherence and the pattern distribution of 
biofilm formation at different locations in the well. Dissolution of the dye allows 
quantification of adherence by measuring the optical density at 590 nm172. 
 
 Motility assays 3.3.2
Two distinct flagella-mediated motility behaviors can be observed in S. Typhimurium 
and P. aeruginosa PAO1, swimming and swarming motility. 
 
3.3.2.1 Swimming assay 
Macroscopic observation of swimming motility occurs in an agar of low concentration 
(0.2-0.3%). Any medium can be used to assess swimming motility with a low 
concentration agar.  
 
3.3.2.2 Swarming assay 
Macroscopic observation of swarming motility requires a specific medium and higher 
agar concentration (0.4-0.8%). For S. Typhimurium, cells are inoculated in the agar 
plate. The concentration of the agar > 0.4% will promote surface motility. For 
P. aeruginosa PAO1, bacteria are inoculated as a spot in the middle of the plate and 
radially spread from the inoculum site173.  
These two analyses can be complemented with evaluation of flagellin 
expression. 
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 Virulence associated phenotypes  3.3.3
Bacterial crossing of the epithelial lining is a key virulence event in the 
gastrointestinal disease caused by S. Typhimurium. Invasion of epithelial cells 
requires different effector proteins belonging to the iT3SS-1. To characterize how 
gene products associated with biofilm phenotypes affect virulence and to identify of 
the c-di-GMP signaling network components, which contribute to virulence 
regulation, we used several in vitro assays. 
We utilized the human colon adenocarcinoma HT-29 cell line to evaluate the 
ability of different S. Typhimurium mutants to invade eukaryotic cells. Prior to 
invasion, the bacteria were grown in hyperosmotic medium and standing culture 
(microaerophilic conditions) to mimic the gastro-intestinal tract conditions. The 
infection was performed by co-incubation of cells with bacteria for 1 h. Bacteria were 
adjusted to 107 colony forming units.ml-1 (CFU) and 90 % confluent epithelial cells 
were used. The length of infection has been chosen in order to observe the early 
stage of invasion. 
 
3.3.3.1 Invasion assay 
One hour post-infection, the cells are treated with gentamycin to kill non-invading 
bacteria, gently washed and resuspended with trypsin to allow determination of 
intracellular bacteria by CFU counts. The purpose of this experiment was to analyze 
the relation between specific c-di-GMP genotypes and invasion phenotypes. 
 
3.3.3.2 Interleukin 8 quantification  
The pro-inflammatory response induced by TLR-5 activation in the HT-29 cell line is 
evaluated one hour post-infection by measuring the secretion of IL-8 into the 
supernatant. Measurement of IL-8 was performed by enzyme linked immune sorbent 
assay (ELISA).  
 
3.3.3.3 SipA expression 
The expression of the effector protein SipA was evaluated by western blot analysis.  
As SipA is one of the first proteins secreted by iT3SS-1, we choose it as a 
representative protein. The supernatant of the bacterial culture was analyzed after 
repeated centrifugation of the bacterial culture and precipitation of the secreted 
proteins with trichloroacetic acid (TCA). Western blot analysis was performed to 
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quantify the expression of β-lactamase of a chromosomally encoded 
SipA-β-lactamase fusion174.  
 
3.4 HIGH PERFORMANCE LIQUID CHROMATOGRAPHY  
C-di-GMP detection and quantification was performed by HPLC. The assay allows 
quantitative evaluation of c-di-GMP metabolizing proteins under invasion conditions. 
For the sample preparation, mid-logarithmic bacterial culture was inactivated by 
formaldehyde and lysed by heating to 95°C175, 176. The nucleotides were extracted 
with ethanol. The bacterial extract was dissolved in HPLC grade water and passed 
through a Supelcosil LC-18-T column.  
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4 RESULTS  
 
4.1 PAPER 1: DISSECTING THE C-DI-GMP SIGNALING NETWORK 
REGULATING MOTILITY IN SALMONELLA ENTERICA SEROVAR 
TYPHIMURIUM. 
 
Aim: to identify and correlate the components of the c-di-GMP signaling network 
involved in bacterial motility regulation. 
Besides biofilm formation, motility is the major target of regulation by 
c-di-GMP signaling7. In S. Typhimurium and other bacteria, high concentration of 
c-di-GMP inhibits motility, while low concentration promotes movement99, 126. 
In S. Typhimurium and E. coli, various studies have demonstrated that the 
phosphodiesterase YhjH positively affects swimming and swarming motility85, 126, 177.  
Deletion of this phosphodiesterase elevates the concentration of c-di-GMP and, in 
coordination with the PilZ domain protein YcgR, downregulates motility130, 131, 178. 
Also cellulose production inhibits motility by mechanically inhibiting flagella 
rotation132. The transcriptional regulator CsgD plays a central role in adhesion and 
biofilm regulation, but its role in motility has not been addressed in 
S. Typhimurium179.  
In this work, we confirmed that promotion of motility by YhjH is due to 
regulation by c-di-GMP, while yhjH does not affect the expression level of flagellin 
proteins FliC and FljB. By observation of the motility behavior on swimming and 
swarming agar plates at 28°C and 37°C, we identified STM2672, STM4551 and 
STM1987 as key diguanylate cyclases working in concert with YhjH in motility 
regulation (Fig. 10). Subsequent deletion of all these diguanylate cyclases in the 
yhjH mutant restored motility to the wild type level. In addition, deletion of STM2123 
restored motility in the triple mutant background ΔyhjHΔ1987Δ4551. These results 
indicate that the genetic background can be a determinative factor to define the role 
of diguanylate cyclases. Subsequently, we investigated the partnership between 
each of the key diguanylate cyclases and motility associated PilZ domain proteins 
YcgR or BcsA. We could clearly identify an association between STM2672 and 
YcgR, STM1987 and BcsA, whereas STM4551 is associated with both receptors.  
As previously shown for swimming motility, deletion of the two PilZ 
domain proteins in the ΔyhjH background gradually restored swarming to the wild 
type level. Elevated concentration of c-di-GMP in the triple mutant 
ΔyhjHΔycgRΔbcsA decreased swarming suggesting that a third receptor could be 
involved. Unexpectedly, CsgD does not affect flagella-mediated motility. Neither the 
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csgD mutant nor CsgD overexpression had an effect on motility compared to the wild 
type. This finding is surprising, since in E. coli, CsgD expression inhibits motility180. 
Also CsgD, directly or indirectly transcriptionally regulates components of the 
flagellar regulon of S. Typhimurium181. Surprisingly, complementation of the ΔyhjH 
mutant with a plasmid containing yhjH provoked a phase variation from FliC to FljB 
expression suggesting the EAL domain protein to be involved in this phenomenon. 
A                  B 
 
 
 
 
Figure 10: Identification of key diguanylate cyclases working in concert with 
ΔyhjH. (A) Swimming motility after 4 hours of incubation at 37°C. 0: negative control, 1: wild 
type, 2:ΔyhjH, 3: ΔyhjHΔ2672, 4: ΔyhjHΔ4551, 5: ΔyhjHΔ1987, 6: ΔyhjHΔ1283. 
(B) Complementation of double mutants with the diguanylate cyclase STM4551 and 
STM4551 containing a mutation in the catalytic site. 
 
4.2 PAPER 2: THE EAL-LIKE PROTEIN STM1697 REGULATES VIRULENCE 
PHENOTYPES, MOTILITY AND BIOFILM FORMATION IN SALMONELLA 
TYPHIMURIUM. 
 
Aim: to establish the molecular mechanism of the non-canonical EAL domain protein 
STM1697 to affect bacterial phenotypes. 
 A previous study (Paper 4) has identified roles for GGDEF/EAL domain proteins in 
virulence-associated phenotypes, invasion and IL-8 production. Screening for 
regulation of the invasion phenotype revealed that the non-canonical EAL domain 
protein STM1697 behaved oppositely to established phosphodiesterases. STM1697 
belongs to the third class of EAL domain proteins that do not possess conserved 
signature motifs and is characterized as non-canonical EAL domain protein182.  
To analyse the molecular mechanism behind this unconventional phenotype, 
we first assessed bacterial phenotypes affected by the c-di-GMP signaling network 
such as rdar biofilm morphotype, expression of the biofilm regulator CsgD, secretion 
of SipA and motility. Usually, EAL domain proteins established as 
phosphodiesterases downregulate the rdar morphotype and CsgD expression171. 
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In bacterial-host interaction, phosphodiesterases upregulate the invasion phenotype 
and secretion of SipA (Paper 4). However, STM1697 regulates all those different 
phenotypes in the opposite way.  
Binding study and enzymatic analysis of purified STM1697 showed that this 
non-canonical EAL domain has lost its ability to bind and degrade c-di-GMP, which 
was in accordance with bioinformatic analysis. The differential scanning calorimetric 
profil of the positive control Ykul displayed an increase in unfolding temperature in 
the presence of c-di-GMP. We did not observe a change in unfolding temperature for 
STM1697 revealing that STM1697 does not bind c-di-GMP.  
STM1697 affected biofilm, motility and virulence phenotypes in a similar way 
as the non-canonical EAL domain protein YdiV183. Consequently, we investigated 
the role of STM1697 in interference with the flagella regulon. STM1697 affected 
transcription of the class 2 gene fliA and class three genes fliC and yhjH. 
Transcription of the class 1 flhD was not affected by STM1697, suggesting that 
STM1697 interacts post-transcriptionally with FlhD4C2. Indeed, size exclusion 
chromatography with purified components showed that FlhD2 interacts with 
STM1697 and a subsequent electrophoretic mobility shift assay showed that this 
interaction inhibits the ability of FlhD4C2 to bind to a target promoter. Preliminary 
mutant analysis indicated that STM1697 has a distinct interface to bind to FlhD2 
compared to STM1344. Of note, STM1697 additively works with STM1344 in motility 
and virulence regulation. 
We also hypothesized, that STM1697 inhibits invasion of the gastrointestinal 
cell line HT-29 through inhibition of motility. In line with this hypothesis, deletion of 
motility components, the flagellin proteins FliC and FljB, the motor component MotA 
and chemotaxis components CheY, CheZ and CheA affected invasion. A decrease 
in invasion in those mutants suggested that not only flagellin components but also 
motor components and chemotaxis components affect invasion. STM1697 has an 
indirect impact on rdar morphotype biofilm formation through inhibition of FlhD4C2 via 
inhibition of the class 3 promoter gene yhjH. Interestingly, STM1697 is not functional 
in the laboratory strain S. Typhimurium LT2. 
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4.3 PAPER 3: RAPID PREPARATION OF BACTERIAL FLAGELLA FROM 
SALMONELLA ENTERICA SEROVAR TYPHIMURIUM. 
Aim: to simplify pre-existent method for bacterial flagellin analysis of secreted 
flagellin and make it accessible through the openbiology website. 
A semi-quantitative analysis of the flagellin secretion polymerized form complements 
the phenotypic motility assay. Based on a pre-existing protocol, we developed a 
protocol upon request of the website bioprotocol.org. We used this approach to 
quantify the amount of polymerized flagellin and also observed a flagellin switch 
between the phase 2 to phase 1, potentially mediated by the EAL domain protein 
(Paper 1 and Paper 2). During the elaboration of this protocol we paid a special 
focus on the following features: sensitivity: detection of clearly different signals for 
FliC and FljB, feasibility: reproducibility, reduction of the time procedure and 
chemicals used and last criterium specifity: the flagellin are the major proteins 
secreted in the supernatant184. In our case, we could clearly identify a signal at 
51.6 kDa for FliC and 52.5 kDa for FljB (Fig. 11). Semi quantitative analysis can be 
performed to determine if the amount of flagellin is different from the wild type control 
with software like Image J (Paper 1). This procedure can also be adapted to isolate 
flagellin from other bacterial species. 
 
Figure 11: Observation of monomeric flagellin on SDS-PAGE protein gel. 
Observation of flagellin expression after Coomassie blue staining. FljB: 52.5 kDa, FliC: 
51.6 kDa. 1: wild type, 2: ΔyhjH, 3: complementation of ΔyhjH with pBAD30 containing yhjH, 
4: negative control, ΔfliC ΔfljB 5: ΔfljB, 6: ΔfliC. 
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4.4 PAPER 4: COMPLEX C-DI-GMP SIGNALING NETWORKS MEDIATE 
TRANSITION BETWEEN VIRULENCE PROPERTIES AND BIOFILM 
FORMATION IN SALMONELLA ENTERICA SEROVAR TYPHIMURIUM 
 
Aim: to examine how c-di-GMP signaling modulates virulence phenotypes in 
S. Typhimurium. 
Previous experiments showed that c-di-GMP affects at least two virulence properties 
in S. Typhimurium, invasion of HT-29 cells and IL-8 induction in HT-29 cells upon 
incubation with bacteria136. In Lamprokostopoulou et al., 2010, we used 
overexpression of a diguanylate cyclase which produced five hundred times higher 
intracellular level of c-di-GMP compared to the wild type concentration136. Here, we 
analysed the effect of individual GGDEF, GGDEF-EAL and EAL domain proteins on 
virulence phenotypes invasion, secretion of SipA, IL-8 production as well as in vivo 
colonization and systemic spread of the infection in the streptomycin treated mouse 
model.  
For each phenotype investigated, we could observe an opposite effect 
upon deletion of a distinct panel of GGDEF and EAL domain proteins of variable 
severity depending on the mutant. For invasion and IL-8, deletion of the GGDEF 
domain proteins lead to an increase in the invasion phenotypes and IL-8 production, 
in contrast, deletion of EAL domain proteins decreased the level of invasion as the 
key virulence phenotype. Complementation of GGDEF and EAL domain mutants 
with the GGDEF domain protein STM4551 or the EAL domain protein YhjH, restored 
the phenotype in invasion or IL-8 production to the wild type level respectively. 
Complementation with a catalytically inactive mutant exhibited a similar phenotype 
as the deletion mutant. These results confirm a role of c-di-GMP signaling in 
virulence phenotypes at a physiological relevant concentration.  
To preliminary analyse the pathways leading to virulence suppression 
by c-di-GMP, we determined that the cellulose synthase BcsA and the biofilm 
regulator CsgD are required for inhibition of invasion and IL-8 production upon high 
c-di-GMP level. An exception was the mutant yhjH, whereby deletion of csgD did not 
recover the wild type invasion level. Another interesting point worth to mention is, 
that some c-di-GMP signaling network proteins presented an unconventional 
invasion phenotype like the non-canonical EAL domain protein STM1697 and the 
GGDEF domain protein STM1283, for instance. Secretion of SipA was also 
regulated by GGDEF and EAL proteins in agreement with the phenotype observed 
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in invasion (Fig. 12), but the complementation experiments suggested that the 
catalytic activity is not required for secretion of effector proteins.  
To assess the virulence modulation by c-di-GMP in vivo, we did caecum 
colonization and systemic organ colonization experiments in the 
streptomycin-treated mouse model. Several c-di-GMP metabolizing proteins exhibit 
a pronounced phenotype in invasion and gut colonization, but no correlation 
between in vivo and in vitro experiments can be drawn. 
A   B 
 
Figure 12: Screening of c-di-GMP metabolizing proteins for a phenotype in 
invasion and secretion of the SipA effector protein. (A) Screening of the c-di-GMP 
metabolizing proteins for invasion of the HT-29 epithelial cell line. The GGDEF domain 
proteins STM4551 and STM1987, and the EAL domain proteins YhjH and STM4264 present 
the most pronounced phenotype observed in that assay. (B) The invasion results could be 
correlated with the amount of secretion of the effector protein SipA. 
 
4.5 PAPER 5: ROLE OF THE SURFACTANT PROTEIN C ROLE IN GROWTH 
INHIBITION, BIOFILM FORMATION AND MOTILITY OF PSEUDOMONAS 
AERUGINOSA PAO1 
 
Aim: to identify a possible effect of the surfactant protein C on P. aeruginosa PAO1 
adaptive behavior and possible interaction with surface appendages  in order to 
improve synthetic surfactant engineering. 
The main function of the surfactant protein C is to maintain stability in the lung and 
take part of the innate immunity of this organ, but little is known about its function. 
First, we determined the antimicrobial activity of different surfactant protein C 
variants (synthetic, truncated-SP-C1 and mature version of the surfactant). Then, we 
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analyzed their role in different bacterial adaptive behaviors such as biofilm formation 
and motility.  
We did not detect any microbial activity for the different versions of the 
surfactant protein C tested, but we could observe a 30% decrease in biofilm 
formation in the presence of SP-C1 compared to the control. Motility experiments 
indicated that swimming activity of P. aeruginosa PAO1 is not affected by 
pre-incubation with SP-C1, while swarming activity of the bacteria is decreased by 
25% compared to the control. Swarming activity in P. aeruginosa requires the 
flagellum and type IV pili185. Preliminary analysis by microscopy suggested that 
surfactant protein C induces bacterial clumping in liquid culture. The biofilm assay on 
polystyrene support confirms the bacterial clumping with a preponderant staining at 
the bottom of the well.  
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5 DISCUSSION 
 
In this thesis, the regulation of motility by c-di-GMP signaling in S. Typhimurium was 
analyzed in detail. In general, besides biofilm formation, motility is a major target of 
c-di-GMP signaling in bacteria7, 186. In S. Typhimurium, motility is mainly regulated at 
the post-translational level, while in other bacteria, motility can also be regulated at 
the transcriptional level by c-di-GMP130, 131, 178. For example, in P. aeruginosa, the 
flagellar regulon activator FleQ is a c-di-GMP responsive transcription factor7. 
Of note, in S. Typhimurium, the non-canonical EAL proteins regulate the flagellar 
regulon on the level of the major transcriptional regulator FlhD4C2. STM1697 and 
YdiV can interact with FlhD4C2 and prevent its binding to the target promoter
187 . 
The interaction with the FlhD4C2 interface is different for YdiV and STM1697, which 
can explain their additive effect on motility and virulence phenotypes (Paper 2). 
The post-translational regulation of FlhD4C2 is complex, as DnaK and the flagellar 
regulon component FliT regulate FlhD4C2 functionality
117, 188. 
 The phosphodiesterase YhjH is specifically involved in 
motility in S. Typhimurium and E. coli85, 178. Additional EAL domain proteins 
involved in motility in S. Typhimurium are the EAL domain protein STM0343 and 
the non-canonical STM0551189, 190. The effect of yhjH is probably local as deletion 
of yhjH only marginally increased the level of c-di-GMP in the cell. In any case, 
deletion of yhjH causes YcgR to interact with FliG and via FliM to induce a bias in 
the rotation of the flagellar filament131, 183. Our study showed three different 
diguanylate cyclases STM2672, STM4551, STM1987 to be involved in motility 
regulation in S. Typhimurium177, 178. This set of diguanylate cyclases is overlapping 
but distinct from the diguanylate cyclases down-regulating motility in E. coli178. 
At the receptor level, deletion of the two PilZ domain proteins YcgR and BcsA 
gradually restored the motility in S. Typhimurium107, 132. In the triple mutant 
ΔyhjHΔycgRΔbcsA, overexpression of the diguanylate cyclase AdrA decreased 
swarming motility. This decrease indicates the potential presence of a third 
c-di-GMP receptor. Complementary to the motility phenotype, we investigated 
polymerized flagellin present in the different c-di-GMP mutants. In line with the 
literature, yhjH does not alter expression of polymerized flagellin (Paper 1). 
The switch in flagellin expression with upregulation of FliC, while FljB is 
downregulated upon the deletion of STM0343 indicates that STM0343 expresses 
phosphodiesterase activity in vivo as the phenotype of the switch between FliC and 
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FljB is consistent with our results that the EAL domain protein causes an 
expression switch between FliC and FljB. In addition, a STM0343 mutant displays 
reduced motility. In P. fluorescens, GacS and SadB, c-di-GMP associated proteins 
regulate secretion of FliC by affecting FleQ and consequently transcription of fliC191. 
In summary, our results indicate that regulation of flagellin expression by c-di-GMP 
turnover proteins occurs on more levels than previously anticipated. 
In this work (Paper 2 and 4), we could identify a role of c-di-GMP 
signaling in virulence of S. Typhimurium. Previous work by the Lasa group, using a 
S. enteritidis strain with deletion of all GGDEF domain proteins indicated that 
c-di-GMP signaling is not required for virulence regulation192. In this study, we have 
been using systematic screening of deletion mutants in the c-di-GMP turnover 
proteins to observe a particular phenotype for c-di-GMP signaling in invasion of 
epithelial cells, induction of the IL-8 response, gut colonization and systemic infection 
(Paper 4). Our findings are in line with studies by others, who also found a role of 
c-di-GMP signaling in systemic infection and invasion of Caco-2 cells193, 194. 
Screening of c-di-GMP turnover proteins has also been conducted in other bacteria 
such as P. aeruginosa and X. campestris 97, 195. Our work, seen in the context of the 
literature, also indicates that invasion of epithelial cells and systemic infection are 
generally affected by c-di-GMP signaling in bacteria99, 115, 196. Also, the invasion 
related type three secretion system is a general target for c-di-GMP signaling as in 
the pathogen P. syringae and D. dadantii, phosphodiesterases are modulating the 
expression of the injectisome pilus197, 198.  
C-di-GMP regulates bacterial adaptive behavior from motility to 
virulence factor expression. Furthermore, host components are modulating bacterial 
behavior. As previously shown, the LL-37 inhibits biofilm formation by preventing the 
polymerization of the major curli subunit CsgA in E. coli149. In P. aeruginosa and 
S. epidermidis, LL-37 also inhibits biofilm formation. Recently the small peptide 
1018, an inhibitor of the second messenger (p)ppGpp, has been shown to efficiently 
inhibit biofilm formation in Gram-positive and Gram-negative bacteria199.   
As we have shown that the surfactant component SP-C interferes with 
biofilm formation and swarming motility, we hypothesize that the type IV pili are a 
target of interaction with SP-C since they are involved in both processes. The 
interaction between the SP-C and the bacteria leads to clumping, which can serve 
as a defense mechanism by the host to avoid epithelial damage and increased 
expectoration of the bacteria. This aggregation of bacteria by an innate immune 
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component would work in similar way as nanonets formed by the human α-defensin 
6, which are build up after S. Typhimurium invasion in the gut200. 
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6 CONCLUDING REMARKS AND FUTURE 
PERSPECTIVES 
 
The major conclusions of this thesis are:  
 The c-di-GMP signaling network of S. Typhimurium regulates motility through 
one phosphodiesterase and three diguanylate cyclases.  
 C-di-GMP metabolizing proteins tightly regulate bacterial motility through 
specific interactions with two c-di-GMP receptors.  
 STM1697 affects biofilm formation, motility and invasion of the HT-29 cell line 
through its interaction with FlhD4C2.  
 The panels of c-di-GMP metabolizing proteins, which modulate bacterial 
virulence and host response were defined.  
 The major biofilm components, the transcriptional regulator CsgD and the 
cellulose synthase BcsA are involved in repression of virulence in vitro.  
 Surfactant protein C inhibits biofilm formation and swarming motility of 
P. aeruginosa and might promote aggregation of the bacterial cells in vivo.  
The most immediate work to follow up this thesis would be: 
C-di-GMP regulation of bacterial adaptive behavior 
 Determination of the mechanisms of the specificity of di-guanylate cyclases 
towards cognate receptors involved in motility inhibition. 
 Identification of new c-di-GMP receptors and associated cellular functions.  
 To elucidate the molecular mechanism by which the c-di-GMP signaling 
affects the invasion phenotype. 
 To elucidate the molecular mechanism by which the c- di-GMP signaling 
affects the IL-8 secretion phenotype. 
 Determination of the mechanism how GGDEF and EAL domain proteins 
regulate secretion of the type three secretion effector protein SipA 
independently of c-di-GMP. 
 To characterize the role of other surface appendages involved in bacterial 
behavior such as virulence. 
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Bacterial biofilm and host components  
 Define the molecular mechanism behind the switch of biofilm modes by the 
surfactant protein C.  
 Investigate whether surfactant protein C has a role in adherence and invasion 
of host cells by P. aeruginosa.  
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